Cooling a patient’s body down to slow its metabolic processes has long been used in medical settings to reduce injuries and long-term problems from severe conditions, but it can only currently be done in a well-resourced hospital. New research in tadpoles shows that Donepezil, a widely administered FDA-approved drug used to treat Alzheimer’s Disease, can potential buy patients more time to survive critical injuries and diseases, even when disaster strikes far from a hospital.

From Donald E. Ingber and colleagues, first author Maria Plaza Oliver. Read more in the Harvard Gazette.